(Q42331780)

27 October 2017

0 references

Gaucher disease: resetting the clinical and scientific agenda (English)

1 reference

27 October 2017

1 reference

Pramod K Mistry

1

1 reference

27 October 2017

Neal J Weinreb

series ordinal

2

1 reference

27 October 2017

Roscoe O Brady

series ordinal

3

1 reference

27 October 2017

Gregory A Grabowski

series ordinal

4

1 reference

27 October 2017

language of work or name

1 reference

1 April 2009

1 reference

American Journal of Hematology

27 October 2017

1 reference

27 October 2017

84

1 reference

27 October 2017

4

1 reference

27 October 2017

205-207

1 reference

Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.

27 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Phenotype, diagnosis, and treatment of Gaucher's disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Life expectancy in Gaucher disease type 1

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Enzyme replacement in Gaucher disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Gaucher disease: complexity in a "simple" disorder

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Gaucher disease: a century of delineation and understanding

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Pulmonary hypertension and Gaucher's disease: logical association or mere coincidence?

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Unusual cardiac, renal and pulmonary involvement in Gaucher's disease. Intersitial glucocerebroside accumulation, pulmonary hypertension and fatal bone marrow embolization

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Enzyme replacement therapy for mild patients with Gaucher disease.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Gaucher disease and cancer incidence: a study from the Gaucher Registry.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Gaucher disease, a paradigm for single gene defects.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

The pathology of Gaucher disease.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999876

Gaucher's disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis

17 August 2018

1 reference

12 December 2020

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

1 reference

12 December 2020

Increased risk of cancer in patients with Gaucher disease

1 reference

12 December 2020

Echocardiographic assessment of pulmonary hypertension in Gaucher's disease

1 reference

12 December 2020

Increased incidence of cancer in adult Gaucher disease in Western Europe

1 reference

12 December 2020

Low-dose versus high-dose therapy for Gaucher disease: Goals and markers

1 reference

12 December 2020

Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention

1 reference

12 December 2020

Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention

1 reference

12 December 2020

The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?

1 reference

12 December 2020

Identifiers

DOI

10.1002/AJH.21384

1 reference

27 October 2017

1 reference

27 October 2017

1 reference